Attralus Alternatives & Competitors
12 companies similar to Attralus — Attralus is a biopharmaceutical company creating transformative medicines for pa...
Companies similar to Attralus
CRISPR Therapeutics
Gene-based medicines for patients with serious diseases
Boston, United States
Silver Creek Pharmaceuticals
Rescue cells. Change lives.
South San Francisco, Unit...
Allakos Inc
Antibody-based therapeutics to treat various allergies and diseases
Redwood City, United Stat...
Rival Readout
Competing with Attralus? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Pathalys Pharma
Our mission is to improve the lives of patients through enhanced therapeutics to advance t...
Raleigh, United States
Yaqrit
The Liver Disease Company
London, United Kingdom
Walden Biosciences
Transforming the Treatment of Kidney Disease
Cambridge, United States
Amyl Therapeutics
Restoring clarity in amyloid diseases
Liege, Belgium
Sitryx
Harnessing the power of cell metabolism to develop groundbreaking disease-modifying therap...
Oxford, United Kingdom
AusperBio
Transforming Patient Lives For a Better Tomorrow
San Mateo, United States
FimmCyte
First disease modifying treatment for Endometriosis.
Basel, Switzerland
Bionomics Ltd
Developing novel drug candidates to transform the lives of patients with anxiety and stres...
Australia
About Attralus
Attralus, founded in 2019, is a clinical stage biopharmaceutical company headquartered in the United States. The company is focused on the development of innovative therapies for patients suffering from systemic amyloidosis, a complex disease with few treatment options. Attralus' proprietary technology, pan-amyloid rem...
Development of therapeutic interventions targeting amyloidosis, Pan-amyloid removal technology, Biologics and imaging agent development
Patients with systemic amyloidosis, Healthcare professionals treating amyloidosis, Pharmaceutical partners seeking novel therapies, Investors in biotech innovations
Biopharmaceutical, Systemic Amyloidosis, Transformative Medicines, PAR Therapeutics, Amyloid Removal, Disease Pathology, Peptide-based Agents, Clinical Stage, Therapeutics Development, Organ And Tissue Binding, Universal Pathology Targeting, Disease Reversal, Diagnosis And Treatment, Subtype Treatment
B2B, B2C, B2D
Product Sales, Licensing
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Attralus: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Attralus on 11 Mar 2026. The 12 companies listed here were last checked between 12 Sep 2024 and 3 Jul 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
